{"altmetric_id":4674571,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["jppopenaccess"],"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["149822138415978"],"posts_count":1}},"citation":{"doi":"10.4172\/2153-0645.1000e117","first_seen_on":"2015-10-26T12:53:13+00:00","issns":["2153-0645"],"journal":"Journal of Pharmacogenomics & Pharmacoproteomics","last_mentioned_on":1445863826,"links":["http:\/\/www.omicsonline.org\/clinical-applications-of-ugt1a1-polymorphisms-for-irinotecan-therapy-2153-0645.1000e117.php?aid=4625"],"pdf_url":"http:\/\/www.omicsonline.org\/clinical-applications-of-ugt1a1-polymorphisms-for-irinotecan-therapy-2153-0645.1000e117.pdf","pubdate":"2012-12-10T00:00:00+00:00","publisher":"OMICS Group","title":"Clinical Applications of UGT1A1 Polymorphisms for Irinotecan Therapy","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/clinical-applications-ugt1a1-polymorphisms-irinotecan-therapy"},"altmetric_score":{"score":1.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.25},"context_for_score":null},"demographics":{"poster_types":{"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Researcher":1,"Other":1},"by_discipline":{"Medicine and Dentistry":1,"Biochemistry, Genetics and Molecular Biology":1}}},"geo":{"twitter":{"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/jppopenaccess\/statuses\/658626742614118400","license":"gnip","citation_ids":[4674571],"posted_on":"2015-10-26T12:50:26+00:00","author":{"name":"Pharmacogenomics","url":"http:\/\/omicsonline.org\/jpphome.php","image":"https:\/\/pbs.twimg.com\/profile_images\/855739886644543488\/peQH3AJQ_normal.jpg","description":"The Journal of Pharmacogenomics & Pharmacoproteomics is an international, peer-reviewed journal includes the manuscripts of original research articles.","id_on_source":"jppopenaccess","tweeter_id":"180311511","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":500},"tweet_id":"658626742614118400"}],"facebook":[{"url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1002464266485090&id=149822138415978","license":"public","citation_ids":[4674571],"posted_on":"2015-10-26T12:50:22+00:00","summary":"Clinical Applications of UGT1A1 Polymorphisms for Irinotecan Therapy\nRecent pharmacogenomics studies have made novel contributions in identifying genetic markers which are useful for personalized medicine. One of the examples is Irinotecan. Irinotecan(Camp","author":{"name":"Pharmacogenomics & Pharmacoproteomics","url":"https:\/\/www.facebook.com\/149822138415978","facebook_wall_name":"Pharmacogenomics & Pharmacoproteomics","image":"https:\/\/graph.facebook.com\/149822138415978\/picture","id_on_source":"149822138415978"}}]}}